Stay updated on Mirvetuximab Combo in FRα+ Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Mirvetuximab Combo in FRα+ Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Mirvetuximab Combo in FRα+ Ovarian Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page footer’s revision label has been updated from **v3.5.2** to **v3.5.3**, indicating a change to the site version rather than the study information.
    Difference
    0.0%
    Check dated 2026-04-26T13:33:48.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2. Removed Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-19T04:48:20.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    37 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.0, replacing the previous Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-21T08:42:52.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Revision history updated to add v3.4.3 and remove v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-06T19:33:35.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    Fallopian tube cancer added to the study keywords; the record revision updated from v3.4.1 to v3.4.2.
    Difference
    0.1%
    Check dated 2026-02-13T12:51:18.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    Added Primary peritoneal carcinoma to the terminology and updated the page revision from v3.4.0 to v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-06T09:10:40.000Z thumbnail image

Stay in the know with updates to Mirvetuximab Combo in FRα+ Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Mirvetuximab Combo in FRα+ Ovarian Cancer Clinical Trial page.